Let me introduce the research results of HLB SCIENCE.
Translational Neurodegeneration. 07 December 2021 Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications Hyeon soo Kim, Sujin Kim, Soo Jung Shin, Yong Ho Park, Yunkwon Nam, Chae won Kim, Kang won Lee, Sung-Min Kim, In Duk Jung, Hyun Duk Yang, Yeong-Min Park & Minho Moon https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/s40035-021-00273-y
Nat Commun. 2020 Feb 28;11(1):1137 Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment. Kang TH1, Park JH1, Yang A2,3, Park HJ1, Lee SE1, Kim YS1, Jang GY1, Farmer E3, Lam B4, Park YM5, Hung CF6. https://www.nature.com/articles/s41467-020-14821-z
Angew Chem Int Ed Engl. 2015 Jul 6;54(28):8139-43 Multivalent Polymer Nanocomplex Targeting Endosomal Receptor of Immune Cells for Enhanced Antitumor and Systemic Memory Response. Kim SY1, Heo MB1, Hwang GS2, Jung Y2, Choi DY1, Park YM3, Lim YT4. https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.201501380
Sci Rep. 2016 Dec 2;6:38348 In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy. Han HD1, Byeon Y1, Jang JH2, Jeon HN1, Kim GH1, Kim MG1, Pack CG3, Kang TH1, Jung ID1, Lim YT4, Lee YJ5, Lee JW6, Shin BC7, Ahn HJ8, Sood AK9,10,11, Park YM1. https://www.nature.com/articles/srep38348
Biomaterials. 2017 Jun;130:56-66 Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. Kim SY1, Noh YW1, Kang TH2, Kim JE1, Kim S1, Um SH1, Oh DB3, Park YM4, Lim YT5. https://www.sciencedirect.com/science/article/pii/S0142961217301837?via=ihub
Nat Commun. 2019 Aug 20;10(1):3745 Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence. Song C1, Phuengkham H1, Kim YS2, Dinh VV1, Lee I1, Shin IW1, Shin HS1, Jin SM1, Um SH1, Lee H3, Hong KS3, Jin SM4, Lee E4, Kang TH5, Park YM6, Lim YT7. https://www.nature.com/articles/s41467-019-11730-8
ACS Nano. 2019 Nov 26;13(11):12671-12686 Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy. Kim SY1, Kim S1, Kim JE1, Lee SN1, Shin IW1, Shin HS1, Jin SM1, Noh YW2, Kang YJ2, Kim YS3, Kang TH3, Park YM3, Lim YT1. https://pubs.acs.org/doi/10.1021/acsnano.9b04207